Skip to main content

Newsletter block in header



  • English
  • Kiswahili

You are here

Russian Federation

Arkhangelsk Clinical Tuberculosis Dispensary in Arkhangelsk, northern Russia.   [© MSF/Seymur Veliyev]

No. staff in 2019: 30 | Expenditure in 2019: €1.2 million | Year MSF first work in the country: 1992


In Russia, Médecins Sans Frontières (MSF) is collaborating with health authorities and academic partners in Arkhangelsk region to reduce the burden of drug-resistant tuberculosis (DR-TB) and improve treatment for the disease.

Working in line with the latest World Health Organization recommendations for DR-TB, our teams began providing drugs and technical advice to support the treatment of patients with the most severe forms of TB in Arkhangelsk region in January. By the end of the year, we had supported the treatment of 23 patients. In partnership with Arkhangelsk Regional Ministry of Health, Northern State Medical University and Arkhangelsk Clinical TB Dispensary, we are building on existing expertise and working together to implement novel all-oral short-course regimens. The aim of the collaboration is to provide evidence for future developments in TB policy in Russia and increase the availability of more effective models of treatment.

Our teams have been working in Russia since the early 1990s, running programmes in Moscow, Saint Petersburg, Kemerovo region, Chechnya, Ingushetia and Dagestan.

COVID-19 Coronavirus

Most of the world's countries have reported cases of coronavirus disease COVID-19 and MSF teams in over 70 countries are now racing to respond to the pandemic.  

Find out more